Weight Control for GU/ Kidney Disorder: 80.0% of denials overturned
In 15 California IMR decisions from 2022 to 2024, reviewers overturned 12 (80.0%). In the last five years: 80.0% of 15. 12 were medical-necessity disputes, 3 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2022 | 1 | 100.0% |
| 2023 | 7 | 85.7% |
| 2024 | 7 | 71.4% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 7 | 85.7% | 80.0% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for Wegovy (semaglutide) injection. Wegovy is U.S. Food and Drug Administration (FDA)-approved for adults with obesity or adults who are overweight with one weight-related condition for chronic weight management, to be used with dietary changes and physical activity. In this case, the patient …”
“The physician reviewer found that the patient has requested authorization and coverage for Zepbound auto-injector. The American Association of Clinical Endocrinologists (AACE) emphasized the fact that “excessive adiposity can become dysfunctional and predispose the individual to the development of many medical complications including diabetes mellitus and non-alcoholic fatty liver, in addition, it does support the medical therapy of obesity as …”
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Wegovy auto-injector. The American Gastroenterological Association (AGA) guidelines recommend weight loss medication for patients who have a BMI greater than 30 kg/m2, or a BMI between 27 and 29.9 kg/m2, with weight-related comorbidities, and who have been unable to lose weight with …”
And one the reviewer upheld
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Wegovy. The American Association of Clinical Endocrinologists (AACE) supports medical therapy for the management of obesity due to the increased risk for multiple chronic diseases associated with obesity. Pharmacotherapy for weight loss may be used for patients with a body mass index …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Weight Control denials for GU/ Kidney Disorder overturned?
In 15 California IMR decisions from 2022 to 2024, reviewers overturned 12 (80.0%). In the last five years: 80.0% of 15. 12 were medical-necessity disputes, 3 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.